What does this research mean for the field?

Inhibition of TrkB signaling with ANA-12 alters hepatic mitochondrial enzyme activity and reduces oxidative stress, serum leptin, and ceramide levels in mice with sucrose-induced metabolic stress, although it does not significantly improve systemic insulin resistance. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To examine the impact of pharmacological TrkB receptor inhibition using ANA-12 on hepatic mitochondrial enzyme activities and oxidative stress markers in mice with sucrose-induced insulin resistance.

September 2, 2026Journal of Biochemical and Molecular ToxicologyOpen Access

Inhibition of Tropomyosin Receptor Kinase B Signaling Alters Hepatic Mitochondrial Enzyme Activity and Oxidative Stress in Mice With Sucrose‐Induced Insulin Resistance

View Full Paper

Ask AI

Bookmark

Authors

ABAkın Bodur HZHüseyin Çınar Zihni KKKatip Korkmaz

Discussion

Member takes

Overview

Preclinical study reveals that TrkB receptor inhibition alters hepatic mitochondrial activity and reduces oxidative stress in sucrose-fed mice, indicating a regulatory role in liver metabolism.

Key Points

To examine the impact of pharmacological TrkB receptor inhibition using ANA-12 on hepatic mitochondrial enzyme activities and oxidative stress markers in mice with sucrose-induced insulin resistance.
Male C57BL/6J mice were allocated into four groups: Control, Sucrose (35% solution), Sucrose+DMSO, and Sucrose+ANA-12 (0.5 mg/kg).
Following a 16-week dietary sucrose intervention, mice received daily intraperitoneal injections of ANA-12 or vehicle during the final 21 days.
Hepatic activities of cytochrome c oxidase, superoxide dismutase, and catalase, alongside malondialdehyde, serum metabolic parameters, and BDNF levels, were quantified.
Sucrose feeding significantly elevated body weight, serum insulin, HOMA-IR, cholesterol, and hepatic malondialdehyde, while reducing hepatic BDNF levels.
ANA-12 treatment produced statistically significant decreases in serum leptin and ceramide levels compared to the Sucrose+DMSO group, although reductions in body weight and HOMA-IR were not statistically significant.
TrkB inhibition with ANA-12 significantly increased hepatic cytochrome c oxidase activity, altered superoxide dismutase activity, and decreased hepatic malondialdehyde concentrations relative to vehicle controls.

Cite This Study

Bodur et al. (2026) studied this question.

synapsesocial.com/papers/6a97e29ec562ede874ec6cba https://doi.org/10.1002/jbt.71104

View Full Paper

Ask AI

Bookmark

September 2, 2026Journal of Biochemical and Molecular ToxicologyOpen Access

Inhibition of Tropomyosin Receptor Kinase B Signaling Alters Hepatic Mitochondrial Enzyme Activity and Oxidative Stress in Mice With Sucrose‐Induced Insulin Resistance

View Full Paper

Ask AI

Bookmark

Authors

ABAkın Bodur HZHüseyin Çınar Zihni KKKatip Korkmaz

Discussion

Member takes

Overview

Preclinical study reveals that TrkB receptor inhibition alters hepatic mitochondrial activity and reduces oxidative stress in sucrose-fed mice, indicating a regulatory role in liver metabolism.

Key Points

To examine the impact of pharmacological TrkB receptor inhibition using ANA-12 on hepatic mitochondrial enzyme activities and oxidative stress markers in mice with sucrose-induced insulin resistance.
Male C57BL/6J mice were allocated into four groups: Control, Sucrose (35% solution), Sucrose+DMSO, and Sucrose+ANA-12 (0.5 mg/kg).
Following a 16-week dietary sucrose intervention, mice received daily intraperitoneal injections of ANA-12 or vehicle during the final 21 days.
Hepatic activities of cytochrome c oxidase, superoxide dismutase, and catalase, alongside malondialdehyde, serum metabolic parameters, and BDNF levels, were quantified.
Sucrose feeding significantly elevated body weight, serum insulin, HOMA-IR, cholesterol, and hepatic malondialdehyde, while reducing hepatic BDNF levels.
ANA-12 treatment produced statistically significant decreases in serum leptin and ceramide levels compared to the Sucrose+DMSO group, although reductions in body weight and HOMA-IR were not statistically significant.
TrkB inhibition with ANA-12 significantly increased hepatic cytochrome c oxidase activity, altered superoxide dismutase activity, and decreased hepatic malondialdehyde concentrations relative to vehicle controls.

Cite This Study

Bodur et al. (2026) studied this question.

synapsesocial.com/papers/6a97e29ec562ede874ec6cba https://doi.org/10.1002/jbt.71104

View Full Paper

Ask AI

Bookmark